Literature DB >> 16966932

Small cell lung carcinoma presenting as collapsin response-mediating protein (CRMP) -5 paraneoplastic optic neuropathy.

Rishi Sheorajpanday1, Hans Slabbynck, Wivine Van De Sompel, Danny Galdermans, Ingrid Neetens, Peter Paul De Deyn.   

Abstract

A 77-year-old woman presenting with progressive visual loss in both eyes was found to have small cell lung cancer. Assay for collapsin response-mediating protein (CRMP) -5 was positive suggesting a paraneoplastic optic neuropathy (PON). During treatment of the small cell lung cancer, the patient died of pneumonia and autopsy disclosed neuropathologic abnormalities consistent with PON. This is only the second case of CRMP-5-confirmed PON to report neuropathologic findings.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16966932     DOI: 10.1097/01.wno.0000235578.80051.0e

Source DB:  PubMed          Journal:  J Neuroophthalmol        ISSN: 1070-8022            Impact factor:   3.042


  6 in total

Review 1.  Atypical Optic Neuritis.

Authors:  Eric D Gaier; Katherine Boudreault; Joseph F Rizzo; Julie Falardeau; Dean M Cestari
Journal:  Curr Neurol Neurosci Rep       Date:  2015-12       Impact factor: 5.081

2.  Anti-Collapsing Response-Mediating Protein-5 Antibody-Positive Paraneoplastic Perioptic Neuritis without Typical Neurological Symptoms.

Authors:  Nozomi Igarashi; Hiromasa Sawamura; Toshikatsu Kaburaki; Makoto Aihara
Journal:  Neuroophthalmology       Date:  2016-10-27

3.  Clinical approach to optic neuropathies.

Authors:  Raed Behbehani
Journal:  Clin Ophthalmol       Date:  2007-09

4.  DRP5 is involved in cancer cell growth and predicts poor prognosis in human osteosarcoma.

Authors:  Lin Wang; Weihai Liu; Hengtao Tang; Xianbiao Xie; Changye Zou; Yongqian Wang; Zhenhua Gao; Junqiang Yin
Journal:  Cancer Med       Date:  2017-04-04       Impact factor: 4.452

Review 5.  Paraneoplastic ocular syndrome: a pandora's box of underlying malignancies.

Authors:  Prathama Sarkar; Amit Mehtani; Harish Chandar Gandhi; Jatinder Singh Bhalla; Satish Tapariya
Journal:  Eye (Lond)       Date:  2021-08-03       Impact factor: 4.456

6.  Vision Improvement after Osimertinib Treatment in Paraneoplastic Optic Neuropathy Associated with Lung Adenocarcinoma.

Authors:  Masaomi Kubota; Nobumasa Tamura; Takaaki Hayashi; Euido Nishijima; Haruhiko Yanagisawa; Akira Kojima; Tadashi Nakano
Journal:  Case Rep Ophthalmol Med       Date:  2021-07-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.